Valency and affinity control of aptamer-conjugated nanoparticles for selective cancer cell targeting

• Published in: Journal of controlled release Vol. 355; pp. 228 - 237
• Main Authors: Woythe, Laura, Porciani, David, Harzing, Tessa, van Veen, Stijn, Burke, Donald H., Albertazzi, Lorenzo
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-03-2023
• Subjects: Aptamer avidity and affinity; Cell Line, Tumor; ErbB Receptors; Humans; Multivalency; Nanoparticle targeting; Nanoparticles; Neoplasms - drug therapy; Silica-supported lipid bilayers; Tumor targeting; Multivalency; Nanoparticle targeting; Tumor targeting; Silica-supported lipid bilayers; Aptamer avidity and affinity
• ISSN: 0168-3659; 1873-4995
• DOI: 10.1016/j.jconrel.2023.01.008

Nanoparticles (NPs) are commonly functionalized using targeting ligands to drive their selective uptake in cells of interest. Typical target cell types are cancer cells, which often overexpress distinct surface receptors that can be exploited for NP therapeutics. However, these targeted receptors are also moderately expressed in healthy cells, leading to unwanted off-tumor toxicities. Multivalent interactions between NP ligands and cell receptors have been investigated to increase the targeting selectivity towards cancer cells due to their non-linear response to receptor density. However, to exploit the multivalent effect, multiple variables have to be considered such as NP valency, ligand affinity, and cell receptor density. Here, we synthesize a panel of aptamer-functionalized silica-supported lipid bilayers (SSLB) to study the effect of valency, aptamer affinity, and epidermal growth factor receptor (EGFR) density on targeting specificity and selectivity. We show that there is an evident interplay among those parameters that can be tuned to increase SSLB selectivity towards high-density EGFR cells and reduce accumulation at non-tumor tissues. Specifically, the combination of high-affinity aptamers and low valency SSLBs leads to increased high-EGFR cell selectivity. These insights provide a better understanding of the multivalent interactions of NPs with cells and bring the nanomedicine field a step closer to the rational design of cancer nanotherapeutics.
[Display omitted]